Buchhagen D - Search Results

1

A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.

Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL. Daly MC, et al. Among authors: buchhagen d. Oncogene. 1993 Jul;8(7):1721-9. Oncogene. 1993. PMID: 8390035

2

Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.

Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF, et al. Bodner SM, et al. Among authors: d amico d, buchhagen dl. Oncogene. 1992 Apr;7(4):743-9. Oncogene. 1992. PMID: 1565469

3

Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer.

Cook RM, Burke BJ, Buchhagen DL, Minna JD, Miller YE. Cook RM, et al. Among authors: buchhagen dl. J Biol Chem. 1993 Aug 15;268(23):17010-7. J Biol Chem. 1993. PMID: 8394326 Free article.

4

Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.

Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO. Olopade OI, et al. Among authors: buchhagen dl. Cancer Res. 1993 May 15;53(10 Suppl):2410-5. Cancer Res. 1993. PMID: 7683574

5

Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.

Takahashi T, D'Amico D, Chiba I, Buchhagen DL, Minna JD. Takahashi T, et al. Among authors: d amico d, buchhagen dl. J Clin Invest. 1990 Jul;86(1):363-9. doi: 10.1172/JCI114710. J Clin Invest. 1990. PMID: 2164047 Free PMC article.

6

A chemical mismatch cleavage method useful for the detection of point mutations in the p53 gene in lung cancer.

Curiel DT, Buchhagen DL, Chiba I, D'Amico D, Takahashi T, Minna JD. Curiel DT, et al. Among authors: d amico d, buchhagen dl. Am J Respir Cell Mol Biol. 1990 Nov;3(5):405-11. doi: 10.1165/ajrcmb/3.5.405. Am J Respir Cell Mol Biol. 1990. PMID: 2223098

7

High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.

D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, et al. D'Amico D, et al. Among authors: buchhagen d. Oncogene. 1992 Feb;7(2):339-46. Oncogene. 1992. PMID: 1312696

8

Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H, et al. Chiba I, et al. Among authors: d amico d, buchhagen dl. Oncogene. 1990 Oct;5(10):1603-10. Oncogene. 1990. PMID: 1979160

9

Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.

Nobori T, Szinai I, Amox D, Parker B, Olopade OI, Buchhagen DL, Carson DA. Nobori T, et al. Among authors: buchhagen dl. Cancer Res. 1993 Mar 1;53(5):1098-101. Cancer Res. 1993. PMID: 8382555

10

A PCR-aided transcript titration assay revealing very low expression of a gene at band 3p21 in 33 cells lines derived from all types of lung cancer.

Kok K, van den Berg A, Buchhagen DL, Carritt B, Buys CH. Kok K, et al. Among authors: buchhagen dl. Eur J Hum Genet. 1993;1(2):156-63. doi: 10.1159/000472402. Eur J Hum Genet. 1993. PMID: 8055324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters